Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations.
Journal: The oncologist
Published: April 11, 2024
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical Trials.
Journal: The oncologist
Published: August 10, 2023
Continuation of Third-Generation Tyrosine Kinase Inhibitors in Second-Line Trials for EGFR-Mutated Non-Small-Cell Lung Cancer: Regulatory Considerations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 08, 2023
Trends in the approval of cancer therapies by the FDA in the twenty-first century.
Journal: Nature reviews. Drug discovery
Published: May 10, 2023
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 04, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 28, 2023
Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome.
Journal: Genome biology
Published: March 31, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 13, 2023
Differential Protein Citrullination in Human ER- and ER+ Tumor and Adjacent Healthy Breast Tissue.
Journal: Biochemistry
Published: February 09, 2023
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021.
Journal: JAMA oncology
Published: December 29, 2022
FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 01, 2022
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 30, 2022
Last Updated: 09/26/2026